Home > Boards > US Listed > Biotechs > Delcath Systems Inc. (DCTH)

Not surprised kei,after past week 10Q, Many have

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ash111 Member Profile
 
Followed By 1,047
Posts 190,839
Boards Moderated 1
Alias Born 06/19/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2020 4:06:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2020 7:30:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/5/2020 7:28:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/1/2020 5:05:44 PM
Delcath Strengthens Executive Team with Appointment of Gerard Michel as Chief Executive Officer GlobeNewswire Inc. - 10/1/2020 4:07:17 PM
Delcath Systems, Inc. to Participate in Upcoming Virtual Investor Conferences GlobeNewswire Inc. - 9/10/2020 9:00:10 AM
Delcath to Present at the LD Micro 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 3:00pm ET GlobeNewswire Inc. - 8/25/2020 4:01:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/20/2020 4:25:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 5:26:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 11:11:25 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:22:34 PM
Delcath Systems, Inc. Announces Second Quarter 2020 Results GlobeNewswire Inc. - 8/13/2020 4:01:10 PM
Delcath Schedules Conference Call to Report 2020 Second Quarter Financial Results GlobeNewswire Inc. - 8/6/2020 4:01:10 PM
Delcath to Present at Canaccord Genuity 40th Annual Growth Conference GlobeNewswire Inc. - 8/3/2020 1:48:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2020 5:12:29 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/24/2020 2:07:44 PM
Delcath Announces Leadership Transition GlobeNewswire Inc. - 5/26/2020 8:30:10 AM
Delcath Announces First Quarter 2020 Results GlobeNewswire Inc. - 5/15/2020 6:30:10 AM
Delcath Systems Closes $22.0 Million Public Offering of Common Stock GlobeNewswire Inc. - 5/5/2020 4:05:10 PM
Delcath Systems Announces Pricing of $22 Million Public Offering and Uplisting to the Nasdaq Capital Market GlobeNewswire Inc. - 5/1/2020 10:17:18 AM
ash111   Wednesday, 11/16/16 02:56:52 PM
Re: kei post# 3272
Post # of 49882 
Not surprised kei,after past week 10Q, Many have realized DCTH has legs and current tiny cap ($4m),far away from fair value.
a $4m Cap Co. among Johnson & Johnson ( $JNJ), Merck & Co., Inc ( $MRK), Pfizer Inc. ( $PFE), Novartis AG ( $AGS)
FDA approval +CE Mark too."The FDA has granted us six orphan drug designations, including three orphan designations for the use of the drug melphalan for the treatment of patients with mOM, HCC and ICC. Melphalan/HDS has not been approved for sale in the United States".

http://finance.yahoo.com/news/world-bile-duct-cancer-cholangiocarcinoma-150500717.html

Folks are usually focusing U.S. market only but DCTH is a major P2/P3 World player for Duct Cancer and deep in EU market:
CHEMOSAT Available At Major Cancer Centers Throughout European Region:
1. CE Marked as Class IIb Medical Device with broad indication
2. >300 commercial procedures performed
3. Broad range of tumor types treated
4. Expansion into Turkey March 2016
5. National reimbursement established in Germany for 2016 after <3 years of commercial activity

2H2016:
• German ZE Reimbursement Level Defined
• P2 ICC Cohort Enrollment Completed
• EU Registry Data Readout #2

$32.2 million aggregate proceeds to fund clinical development programs, commercial activities & ongoing operations.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences